What Researchers Did
This retrospective study compared the healing rates of bone marrow edema (BME) in the knee between patients who received hyperbaric oxygen therapy (HBOT) in addition to standard treatment and those who received standard treatment alone.
What They Found
Researchers found that patients receiving hyperbaric oxygen therapy (HBOT) experienced faster healing of bone marrow edema (BME) in the knee compared to those who did not receive HBOT. No significant side effects were reported with HBOT.
What This Means for Canadian Patients
For Canadian patients experiencing bone marrow edema of the knee, hyperbaric oxygen therapy (HBOT) could be a beneficial addition to standard treatment, potentially leading to quicker recovery. This may help reduce pain and improve mobility more rapidly than standard care alone.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
As a retrospective study, this research is limited by its design, which may introduce selection bias and lacks the controlled environment of a randomized trial.